Francesca Paoloni

4.4k total citations
40 papers, 1.1k citations indexed

About

Francesca Paoloni is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Genetics. According to data from OpenAlex, Francesca Paoloni has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 14 papers in Hematology and 11 papers in Genetics. Recurrent topics in Francesca Paoloni's work include Acute Lymphoblastic Leukemia research (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Myeloid Leukemia Research (9 papers). Francesca Paoloni is often cited by papers focused on Acute Lymphoblastic Leukemia research (15 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Acute Myeloid Leukemia Research (9 papers). Francesca Paoloni collaborates with scholars based in Italy, United States and Malaysia. Francesca Paoloni's co-authors include Federico Bilotta, Remo Caramia, Giovanni Rosa, Roberto Delfini, Marco Vignetti, G. Rosa, Andrea Doronzio, Robin Foà, Sabina Chiaretti and Antonio Santoro and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Francesca Paoloni

39 papers receiving 1.0k citations

Peers

Francesca Paoloni
Francesca Paoloni
Citations per year, relative to Francesca Paoloni Francesca Paoloni (= 1×) peers J.C. Souberbielle

Countries citing papers authored by Francesca Paoloni

Since Specialization
Citations

This map shows the geographic impact of Francesca Paoloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Paoloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Paoloni more than expected).

Fields of papers citing papers by Francesca Paoloni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Paoloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Paoloni. The network helps show where Francesca Paoloni may publish in the future.

Co-authorship network of co-authors of Francesca Paoloni

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Paoloni. A scholar is included among the top collaborators of Francesca Paoloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Paoloni. Francesca Paoloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Musco, Stefania, Gabriele Bazzocchi, Jacopo Martellucci, et al.. (2021). Treatments in neurogenic bowel dysfunctions: evidence reviews and clinical recommendations in adults. European Journal of Physical and Rehabilitation Medicine. 56(6). 741–755. 10 indexed citations
3.
Mazzucconi, Maria Gabriella, Roberto Latagliata, Massimo Breccia, et al.. (2020). Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”. European Journal Of Haematology. 105(3). 335–343. 10 indexed citations
4.
Zuin, Massimo, Giuseppe Maggiore, Georgios Loudianos, et al.. (2020). PRO114 Wilson Disease: Unmet NEEDS Emerging from the Italian Population - a Qualitative Survey Study. Value in Health. 23. S710–S710. 2 indexed citations
5.
Chiaretti, Sabina, Monica Messina, Francesca Paoloni, et al.. (2015). CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities. Leukemia Research. 41. 36–42. 35 indexed citations
6.
Santoro, Cristina, Francesca Biondo, Erminia Baldacci, et al.. (2013). Rituximab in Previously Treated Primary Immune Thrombocytopenia Patients: Evaluation of Short- and Long-Term Efficacy and Safety. Acta Haematologica. 132(1). 24–29. 3 indexed citations
7.
Bilotta, Federico, Adrian W. Gelb, Elisabetta Stazi, et al.. (2013). Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials. British Journal of Anaesthesia. 110. i113–i120. 77 indexed citations
8.
Guarini, Anna, M Marinelli, Simona Tavolaro, et al.. (2011). ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression. Haematologica. 97(1). 47–55. 70 indexed citations
9.
10.
Elia, Loredana, Sara Grammatico, Francesca Paoloni, et al.. (2011). Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion gene. American Journal of Hematology. 86(12). 993–997. 5 indexed citations
11.
12.
Messina, Monica, Sabina Chiaretti, Ilaria Iacobucci, et al.. (2011). AICDA expression in BCR/ABL1‐positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profile. British Journal of Haematology. 152(6). 727–732. 5 indexed citations
13.
Giudice, Ilaria Del, Francesca Romana Mauro, M. S. De Propris, et al.. (2010). White blood cell count at diagnosis and immunoglobulin variable region gene mutations are independent predictors of treatment-free survival in young patients with stage A chronic lymphocytic leukemia. Haematologica. 96(4). 626–630. 19 indexed citations
14.
Bilotta, Federico, Remo Caramia, Francesca Paoloni, Roberto Delfini, & Giovanni Rosa. (2009). Safety and Efficacy of Intensive Insulin Therapy in Critical Neurosurgical Patients. Anesthesiology. 110(3). 611–619. 105 indexed citations
15.
Martinelli, Giovanni, Ilaria Iacobucci, Clelia Tiziana Storlazzi, et al.. (2009). IKZF1 (Ikaros) Deletions in BCR-ABL1 –Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report. Journal of Clinical Oncology. 27(31). 5202–5207. 219 indexed citations
16.
Bilotta, Federico, et al.. (2006). Early postoperative cognitive recovery after remifentanil–propofol or sufentanil–propofol anaesthesia for supratentorial craniotomy: a randomized trial. European Journal of Anaesthesiology. 24(2). 122–127. 40 indexed citations
17.
Testi, Anna Maria, Maria Grazia Valsecchi, Valentino Conter, et al.. (2004). Difference in Outcome of Adolescents with Acute Lymphoblastic Leukemia (ALL) Enrolled in Pediatric (AIEOP) and Adult (GIMEMA) Protocols.. Blood. 104(11). 1954–1954. 54 indexed citations
18.
Fabi, Alessandra, Salvatore Di Lauro, L Portalone, et al.. (2003). Is delayed chemotherapy-induced emesis well managed in oncological clinical practice?. Supportive Care in Cancer. 11(3). 156–161. 45 indexed citations
19.
Carlini, Paolo, Antonio Frassoldati, Salvatore De Marco, et al.. (2001). Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): Is a clinical benefit still achievable?. Annals of Oncology. 12(11). 1539–1543. 36 indexed citations
20.
Zeuli, Massimo, et al.. (2001). Capecitabine and oxaliplatin in advanced colorectal cancer: A dose-finding study. Annals of Oncology. 12(12). 1737–1741. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026